DDAVP Melt is indicated for the treatment of vasopressin-sensitive cranial diabetes insipidus or in the treatment of post-hypophysectomy polyuria/polydipsia.
DDAVP Tablets are indicated for the treatment of vasopressin-sensitive cranial diabetes insipidus or in the treatment of post-hypophysectomy polyuria/polydipsia.
DDAVP ® /Desmopressin Injection is indicated as follows :1) Diagnosis and treatment of cranial diabetes insipidus.2) To increase Factor VIII:C and Factor VIII:Ag in patients with mild to moderate haemophilia or von Willebrand's disease undergoing surgery or following trauma.3) To establish renal concentration capacity.4) To treat headache resulting from a lumbar puncture.5) To test for fibrinolytic response.
Desmopressin Melt is indicated for the treatment of primary nocturnal enuresis.
Acute treatment of the headache phase of migraine attacks with or without aura in adults.
Treatment of moderate to severe pain.
Adults: Zofran Melt is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Zofran Melt is indicated for the prevention of post-operative nausea and vomiting (PONV). For treatment of established PONV, administration by injection is recommended. Paediatric Population: Zofran is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months No studies have been conducted on the use of orally administered ondansetron in the prevention and treatment of PONV in children aged ≥1 month, administration by IV injection is recommended for this purpose.
Noqdirna is indicated for symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults (see section 5.1).